<p> (A) Sc-G-12 (right panel) and Sc-G-14 (left panel) are both resistant to azole and geldanamycin and slightly cross-resistant to azole and radicicol, relative to their parental strains (above). (B) Resistance to azole and geldanamycin in Sc-G-14 is attributable to <i>HSC82<sup>I117N</sup></i>. Replacing the ancestral allele with the <i>HSC82<sup>I117N</sup></i> allele expressed on a plasmid increases resistance of the ancestral strain to the level observed in Sc-G-14, while replacing the <i>HSC82<sup>I117N</sup></i> allele with the ancestral allele on a plasmid abrogates resistance of Sc-G-14. (C) Deletion of <i>HSC82</i> in Sc-G-12 or its parental strain phenocopies resistance of Sc-G-12, suggesting that <i>HSC82<sup>K385*</sup></i> con...
International audienceABSTRACT TAC1 (for transcriptional activator of CDR genes) is critical for the...
International audienceABSTRACT TAC1 (for transcriptional activator of CDR genes) is critical for the...
<p><b>A)</b><i>RGD1</i> was deleted from a clinical isolate obtained late in treatment from a patien...
<div><p>The evolution of drug resistance in fungal pathogens compromises the efficacy of the limited...
<p>(A) Sc-F-1 is resistant to azole and FK506 and cross-resistant to azole and cyclosporin A. (B) Re...
<p>(A) Each <i>C. albicans</i> lineage is resistant to high concentrations of FK506 or cyclosporin A...
Principal mechanisms of resistance to azole antifungals include the upregulation of multidrug transp...
<p>A) Experimental populations were initiated with <i>S. cerevisiae</i> and <i>C. albicans</i> strai...
Invasive fungal infections caused by the pathogen Candida albicans have transitioned from a rare cur...
<p>(A) Mild inhibition of Hsp90 not only reverses AmB resistance but selectively kills AmB-resistant...
The evolution of drug resistance is occurring rapidly and threatening our arsenal of antimicrobials....
International audienceBackground: Azoles and echinocandins are the 2 main classes of antifungal agen...
<p>Levels of resistance to azole and FK506 (A, B) or azole and geldanamycin (C–E) of evolved strains...
A phenomenon of increasing resistance of Candida spp. to azoles has been observed for several years ...
International audienceABSTRACT TAC1 (for transcriptional activator of CDR genes) is critical for the...
International audienceABSTRACT TAC1 (for transcriptional activator of CDR genes) is critical for the...
International audienceABSTRACT TAC1 (for transcriptional activator of CDR genes) is critical for the...
<p><b>A)</b><i>RGD1</i> was deleted from a clinical isolate obtained late in treatment from a patien...
<div><p>The evolution of drug resistance in fungal pathogens compromises the efficacy of the limited...
<p>(A) Sc-F-1 is resistant to azole and FK506 and cross-resistant to azole and cyclosporin A. (B) Re...
<p>(A) Each <i>C. albicans</i> lineage is resistant to high concentrations of FK506 or cyclosporin A...
Principal mechanisms of resistance to azole antifungals include the upregulation of multidrug transp...
<p>A) Experimental populations were initiated with <i>S. cerevisiae</i> and <i>C. albicans</i> strai...
Invasive fungal infections caused by the pathogen Candida albicans have transitioned from a rare cur...
<p>(A) Mild inhibition of Hsp90 not only reverses AmB resistance but selectively kills AmB-resistant...
The evolution of drug resistance is occurring rapidly and threatening our arsenal of antimicrobials....
International audienceBackground: Azoles and echinocandins are the 2 main classes of antifungal agen...
<p>Levels of resistance to azole and FK506 (A, B) or azole and geldanamycin (C–E) of evolved strains...
A phenomenon of increasing resistance of Candida spp. to azoles has been observed for several years ...
International audienceABSTRACT TAC1 (for transcriptional activator of CDR genes) is critical for the...
International audienceABSTRACT TAC1 (for transcriptional activator of CDR genes) is critical for the...
International audienceABSTRACT TAC1 (for transcriptional activator of CDR genes) is critical for the...
<p><b>A)</b><i>RGD1</i> was deleted from a clinical isolate obtained late in treatment from a patien...